Search research articles
Contact Us
Filters
Showing results (121-130 of 134) with videos related to
Page
of 14
Sort By:
Viruses
|
January 21, 2023
Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model
Ezechiel Ngoufack Jagni Semengue, Joseph Fokam, Naomi-Karell Etame, et al.
Microbiology Spectrum
|
October 19, 2022
Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir-Containing Regimens in Resource-Limited Settings
Joseph Fokam, Ezechiel Ngoufack Jagni Semengue, Evariste Molimbou, et al.
Frontiers in Immunology
|
August 30, 2023
Inflammatory profile of vertically HIV-1 infected adolescents receiving ART in Cameroon: a contribution toward optimal pediatric HIV control strategies
Aude Christelle Ka'e, Aubin Joseph Nanfack, Georgia Ambada, et al.
Open Forum Infectious Diseases
|
July 23, 2025
HIV-1 Drug Resistance in Children and Implications for Pediatric Treatment Strategies: A Systematic Review and Meta-analysis
Joseph Fokam, Aude Christelle Ka'e, Bouba Yagai, et al.
BMC Infectious Diseases
|
May 5, 2025
Viral dynamics and factors associated with duration of COVID-19 positivity: evidence from the first-three epidemiological waves in Cameroon
Joseph Fokam, Aurelie Minelle Kengni Ngueko, Alex Durand Nka, et al.
Diagnostic Microbiology and Infectious Disease
|
February 5, 2026
Evaluation of two bioinformatic algorithms for the interpretation of HIV-1 drug resistance and subtyping in Cameroon: Translational application for ART optimization in low-and middle-income countries
Joseph Fokam, Naomi-Karell Etame, Ezechiel Ngoufack Jagni Semengue, et al.
Journal of the International Association of Providers of AIDS Care
|
December 23, 2024
Plasma Viral Load of 200 Copies/mL is a Suitable Threshold to Define Viral Suppression and HIV Drug Resistance Testing in Low- and Middle-Income Countries: Evidence From a Facility-Based Study in Cameroon
Collins Ambe Chenwi, Rachel Audrey Nayang Mundo, Alex Durand Nka, et al.
Journal of Clinical Laboratory Analysis
|
February 2, 2026
Diagnostic Concordance of Two- and Three-Gene SARS-CoV-2 Molecular Assays in Cameroon: Implications for Efficient Pandemic Response in Low- and Middle-Income Countries
Aurelie Minelle Kengni Ngueko, Sandrine Claire Djupsa Ndjeyep, Ezechiel Ngoufack Jagni Semengue, et al.
PLOS Global Public Health
|
March 19, 2025
Disparities in anti-SARS-CoV-2 reactivity according to vaccines administered in the era of omicron in Cameroon: Lessons for future outbreak response
Ezechiel Ngoufack Jagni Semengue, Desire Takou, Marina Potesta, et al.
Medicine
|
May 19, 2025
Confirmed virological failure following enhanced adherence counseling among virally unsuppressed children and adolescents on dolutegravir-based versus other regimens: Evidence from a cohort analysis in Cameroon
Yagai Bouba, Aude Christelle Ka'e, Davy-Hyacinthe Anguechia Gouissi, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 134) with videos related to
Sort By:
Page
of 14
Viruses
|
January 21, 2023
Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model
Ezechiel Ngoufack Jagni Semengue, Joseph Fokam, Naomi-Karell Etame, et al.
Microbiology Spectrum
|
October 19, 2022
Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir-Containing Regimens in Resource-Limited Settings
Joseph Fokam, Ezechiel Ngoufack Jagni Semengue, Evariste Molimbou, et al.
Frontiers in Immunology
|
August 30, 2023
Inflammatory profile of vertically HIV-1 infected adolescents receiving ART in Cameroon: a contribution toward optimal pediatric HIV control strategies
Aude Christelle Ka'e, Aubin Joseph Nanfack, Georgia Ambada, et al.
Open Forum Infectious Diseases
|
July 23, 2025
HIV-1 Drug Resistance in Children and Implications for Pediatric Treatment Strategies: A Systematic Review and Meta-analysis
Joseph Fokam, Aude Christelle Ka'e, Bouba Yagai, et al.
BMC Infectious Diseases
|
May 5, 2025
Viral dynamics and factors associated with duration of COVID-19 positivity: evidence from the first-three epidemiological waves in Cameroon
Joseph Fokam, Aurelie Minelle Kengni Ngueko, Alex Durand Nka, et al.
Diagnostic Microbiology and Infectious Disease
|
February 5, 2026
Evaluation of two bioinformatic algorithms for the interpretation of HIV-1 drug resistance and subtyping in Cameroon: Translational application for ART optimization in low-and middle-income countries
Joseph Fokam, Naomi-Karell Etame, Ezechiel Ngoufack Jagni Semengue, et al.
Journal of the International Association of Providers of AIDS Care
|
December 23, 2024
Plasma Viral Load of 200 Copies/mL is a Suitable Threshold to Define Viral Suppression and HIV Drug Resistance Testing in Low- and Middle-Income Countries: Evidence From a Facility-Based Study in Cameroon
Collins Ambe Chenwi, Rachel Audrey Nayang Mundo, Alex Durand Nka, et al.
Journal of Clinical Laboratory Analysis
|
February 2, 2026
Diagnostic Concordance of Two- and Three-Gene SARS-CoV-2 Molecular Assays in Cameroon: Implications for Efficient Pandemic Response in Low- and Middle-Income Countries
Aurelie Minelle Kengni Ngueko, Sandrine Claire Djupsa Ndjeyep, Ezechiel Ngoufack Jagni Semengue, et al.
PLOS Global Public Health
|
March 19, 2025
Disparities in anti-SARS-CoV-2 reactivity according to vaccines administered in the era of omicron in Cameroon: Lessons for future outbreak response
Ezechiel Ngoufack Jagni Semengue, Desire Takou, Marina Potesta, et al.
Medicine
|
May 19, 2025
Confirmed virological failure following enhanced adherence counseling among virally unsuppressed children and adolescents on dolutegravir-based versus other regimens: Evidence from a cohort analysis in Cameroon
Yagai Bouba, Aude Christelle Ka'e, Davy-Hyacinthe Anguechia Gouissi, et al.
Page
of 14